SPL 0.53% 9.5¢ starpharma holdings limited

For the new Dual Protect to become the product of choice its...

  1. 426 Posts.
    For the new Dual Protect to become the product of choice its imperative that any myths or negatives are dispelled.

    Reading over the comments section from my previous attachment, I noticed a number of people commenting (below the article). Some had labels such as professor, medical analyst and one was a member of a HIV organization. For the Dual Protect to be a great success I would think it needs to win over the main players such as these groups.

    I went looking for actual studies and located this article, which lists a study in the USA of the gel. Reassuringly, the company replied to the findings (see below).

    http://www.huffingtonpost.com/2014/07/24/vivagel-condom_n_5617600.html
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.001(0.53%)
Mkt cap ! $38.96M
Open High Low Value Volume
9.5¢ 9.5¢ 9.4¢ $2.952K 31.16K

Buyers (Bids)

No. Vol. Price($)
1 249999 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 12.46pm 12/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.